PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Half of children with ADHD adhere to prescribed medication

methylphenidateatomoxetineamphetaminestimulantsnon-stimulantsADHDpediatricmedication adherencesystematic reviewmeta-analysispharmacist counseling Psychiatry / Psychopharmacology
Also in Pediatrics

Background Information

Adherence to ADHD medication is only 43.6% in youth.

Understanding factors that influence medication adherence in children with ADHD can enhance treatment effectiveness and avoid adverse outcomes. The pooled medication adherence rate was 43.6%, and factors such as parental agreement and medication education significantly improved adherence. The study highlights modifiable factors that can boost adherence, though high study heterogeneity suggests variability in results. Targeting modifiable factors like parental education may improve ADHD medication adherence.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Liu J, Kang B, Deng W, Hao Z, Yang C, Zhang L

Citation: Liu J, Kang B, Deng W, et al. Medication adherence and influencing factors in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and meta-analysis. Frontiers in pharmacology. 2026;17:1819206. doi:10.3389/fphar.2026.1819206

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →